is ozempic compounded semaglutide Some Pharmacies Are Offering Unauthorized Alternatives FDA Warns on Certain Forms

Permanent link to this press release: Copy Please set a link in the press area of your homepage to this press release on openPR

FDA's 2026 GLP-1 Warnings: 990 Reports and What They Mean for JoinSkinny Patients FDA has published ongoing warnings about compounded GLP-1 products generally: Dosing errors from measuring doses out of multi-dose vials Use of salt forms (like semaglutide sodium) that haven't been proven safe or effective Adverse events, including hospitalization in some cases As of May 31, 2026: 990 adverse-event reports tied to compounded semaglutide, and more than 730 tied to compounded tirzepatide - FDA notes these reports may be incomplete and don't, by themselves, establish that a compounded drug caused the reported event On April 30, 2026: FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the 503B bulks list - a move that would close the main legal pathway for large-scale outsourcing-facility compounding of these drugs absent a shortage, with a public comment period that ran through June 29, 2026 These are industry-wide regulatory developments, not findings against JoinSkinny or any specific pharmacy named in this article

The manufacturers now sell direct to cash-pay patients for far less: Zepbound runs $299 to $449 per month through LillyDirect by dose, and Wegovy runs $349 per month for standard doses through NovoCare Pharmacy ($199 per month on the first two fills through December 2026)

Our Mexican generic drugs are of the highest quality, selected only from the most reputable manufacturers, and are safe to replace brand name medications costing much more

This blend is typically used in in-vitro, ex-vivo, and analytical laboratory environments, including cellular signaling studies and tissue-model research